CCO Podcasts
Approved HCV Agents
|
|
Gregory T. Everson, MD, FACP, discusses data from AASLD 2008 on strategies for improving hepatitis C treatment response with approved agents and predicting response based on various possible responses and assays.
Date posted: 11/4/2008
| Duration: 3:55
|
Approved HBV Agents
|
|
Robert G. Gish, MD, reviews data from AASLD 2008 on frontline hepatitis B treatment options with approved agents and predicting response based on patient and viral characteristics
Date posted: 11/4/2008
| Duration: 11:08
|
Investigational Agents for Viral Hepatitis
|
|
Stefan Zeuzem, MD, highlights data from AASLD 2008 on investigational agents for viral hepatitis, focusing on new targeted therapies for hepatitis C, as well as markers for HBsAg seroconversion with peginterferon.
Date posted: 11/4/2008
| Duration: 9:07
|
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
|
Featured Content
Strategies for optimizing treatment adherence in patients receiving HBV therapy.
Video and audio podcasts highlighting hot topics in HBV and HCV treatment and management.
Get Capsule Summaries, audio Expert Highlights, and a slideset from Vienna.
|
|